Close Menu

NEW YORK (GenomeWeb) – Telegenetics firm Genome Medical has raised $23 million in a series B financing that it will use to nationally scale its services.

Echo Health Ventures led the financing round, with contributions from new investors LRVHelath, Casdin Capital, Perceptive Advisors, Manatt Venture Fund, and Dreamers Fund. Existing investors, including Canaan Partners, GE Ventures, Illumina Ventures, Kaiser Permanente Ventures, and HealthInvest Equity Partners, also participated in the round.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.